Head-to-Head

Myomo Inc. vs. Zimmer Biomet Holdings, Inc.

MYO

Myomo Inc.

$1.46 +5.04%

VS ZBH

Zimmer Biomet Holdings, Inc.

$99.52 -1.45%

Zimmer Biomet Holdings, Inc. (ZBH) comes out ahead, leading on 7 of 8 compared factors.

Size & Scale

MYOZBH
Market Cap $55.05 million $19.26 billion
Revenue (TTM) $43.26 million $8.51 billion
Net Income (TTM) $-14,507,612 $807.00 million

ZBH leads on 3 of 3 size & scale factors.

Valuation

MYOZBH
P/E Ratio — 24.16
Price / Book 9.44 1.52
Price / Sales 1.27 2.26

MYO and ZBH split the valuation factors evenly.

Profitability

MYOZBH
Net Margin -33.53% 9.48%
Return on Equity -248.87% 6.39%

ZBH leads on 2 of 2 profitability factors.

Dividend

MYOZBH
Dividend Yield — 0.96%
Payout Ratio — 23.30

MYO and ZBH split the dividend factors evenly.

Risk & Sentiment

MYOZBH
Short Interest 1.84% 1.23%

ZBH leads on 1 of 1 risk & sentiment factors.

Dig deeper: MYO overview, MYO financials, ZBH overview, ZBH financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.